Sanofi-Aventis plans malaria vaccine in partnership with Institut Pasteur |
|
|
|
Published
:
Mon, 15 Oct 2007 07:13
|
PARIS (Thomson Financial) - Sanofi-Aventis said its vaccines unit, Sanofi Pasteur, has formed a partnership with Institut Pasteur, a major French health sciences laboratory, to develop a vaccine for malaria, a disease for which there is currently none.The project will parallel efforts by others, including one by Oxford University and several partners, to develop an effective vaccine for the disease, which affects 500 mln people per year, of which 1 mln people die.tfn.paris@thomson.commjs/bsdCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
Print this Story
CORRECTION Sanofi-Aventis, UCB launch allergy drug Xyzal in US 